What is the Jupiter Life Line Hospitals Ltd share price today?

The share price of NSE:JLHL-EQ on 07 Sep 2026 (as of 10:59:36 IST) is ₹285.30.

What is the NSE:JLHL-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:JLHL-EQ 52 week high low range shows a high of ₹340.00 and a low of ₹235.60.

What is the Jupiter Life Line Hospitals Ltd market cap?

As on 07 Sep 2026, Jupiter Life Line Hospitals Ltd market cap is ₹9387.42 Cr.

What is the shareholding pattern of Jupiter Life Line Hospitals Ltd Stock?

The shareholding pattern of Jupiter Life Line Hospitals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 40.91% Foreign Institutional Investors (FII): 9.37% Domestic Institutional Investors (DII): 2.20% Mutual Funds: 10.89% Retail & Others: 36.63% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Jupiter Life Line Hospitals Ltd?

The Price-to-Earnings (PE) ratio of Jupiter Life Line Hospitals Ltd is 50.04, and the Price-to-Book (PB) ratio is 5.40, as on 07 Sep 2026.

Jupiter Life Line Hospitals Share Price

267.80+0.00 (-2.28%)

-11.84% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-2.28%

1 Week

-4.37%

1 Month

-10.36%

3 Month

-2.64%

6 Month

+4.65%

YTD

-3.90%

1 Year

-11.84%

5 Year

10 Year

Max

+37.62%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

266.10

235.60

High

275.00

280.30

312.95

340.00

About

Jupiter Life Line Hospitals Limited is engaged in the business of operating and managing hospitals and clinics in India. The company is among the key multi-specialty tertiary and quaternary healthcare Read more

Hospital & Healthcare Services

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

APOLLOHOSPNSE

MAXHEALTHNSE

MANIPALHOSNSE

FORTISNSE

ASTERDMNSE

MEDANTANSE

NHNSE

KIMSNSE

LALPATHLABNSE

VIJAYANSE

JLHLNSE

LTP

1W Low

1W High

Market cap (₹)

8888.5-56 (-0.63%)

8822.50

9070.50

1,30,273Cr

1046-3.3 (-0.31%)

1029

1072.60

1,02,446Cr

742.5+3.55 (0.48%)

733.20

769.75

1,00,021Cr

877.35-8.65 (-0.98%)

877.35

908.80

67,267Cr

768.65+13.6 (1.80%)

734.35

780

66,295Cr

1506.2+6.8 (0.45%)

1467.60

1527

40,209Cr

1877.7-50.8 (-2.63%)

1870

1932.90

39,270Cr

802-7.85 (-0.97%)

785

818.95

33,529Cr

1961.3+64.4 (3.40%)

1890

1976.20

32,271Cr

1526.5-32.4 (-2.08%)

1505.70

1593.60

16,149Cr

266.2-13.85 (-4.95%)

266.10

280.30

9,051Cr

Jupiter Life Line Hospitals Share Price

267.80+0.00 (-2.28%)

-11.84% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years25%

3 years19%

Last year15%

Compounded Profit Growth

10 years-

5 years-

3 years39%

Last year0%

Stock Price CAGR

10 years-

5 years-

3 years8%

1 year-12%

Return on Equity

10 years15%

5 years19%

3 years17%

Last year13%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	25%	19%	15%
-	-	39%	0%
-	-	8%	-12%
15%	19%	17%	13%

Peer Comparison

Symbol

APOLLOHOSP

MAXHEALTH

MANIPALHOS

FORTIS

ASTERDM

MEDANTA

KIMS

LALPATHLAB

VIJAYA

JLHL

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
8,888.5	₹130273 Cr	62.35	40.39	207.67	₹1942 Cr
1,046	₹102446 Cr	70.32	3.31	19.84	₹1442 Cr
742.5	₹100021 Cr	112.09	1.96	11.95	₹892 Cr
877.35	₹67267 Cr	64.19	3.53	20.1	₹1042 Cr
768.65	₹66295 Cr	208.03	0.31	6.76	₹388 Cr
1,506.2	₹40209 Cr	72.3	5.91	29.85	₹556 Cr
1,877.7	₹39270 Cr	48.12	10.14	65.36	₹806 Cr
802	₹33529 Cr	164.12	1.04	12.74	₹241 Cr
1,961.3	₹32271 Cr	59.55	10.11	42.51	₹505 Cr
1,526.5	₹16149 Cr	86.13	5.16	27.53	₹173 Cr
266.2	₹9051 Cr	48.25	1.14	8.56	₹194 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
—	—	—	—	—	—	—
₹66 Cr	₹66 Cr	₹66 Cr	₹57 Cr	₹51 Cr	₹51 Cr	₹51 Cr
₹0	₹0	₹0	₹0	₹2 Cr	₹0	₹0
₹1479 Cr	₹1291 Cr	₹1103 Cr	₹309 Cr	₹241 Cr	₹188 Cr	₹186 Cr
₹1479 Cr	₹1291 Cr	₹1103 Cr	₹309 Cr	₹241 Cr	₹188 Cr	₹186 Cr
₹1544 Cr	₹1356 Cr	₹1169 Cr	₹366 Cr	₹294 Cr	₹239 Cr	₹237 Cr
₹90,000	₹6 L	-₹30 L	-₹2 Cr	-₹5 Cr	₹7 Cr	₹0
₹501 Cr	₹322 Cr	₹0	₹453 Cr	₹463 Cr	₹418 Cr	₹244 Cr
₹0	₹0	₹0	₹0	₹1 Cr	₹3 Cr	₹0
₹10 Cr	₹7 Cr	₹4 Cr	₹37 Cr	₹33 Cr	₹25 Cr	₹20 Cr
₹66 Cr	₹62 Cr	₹0	₹0	₹0	₹0	₹0
₹16 Cr	₹11 Cr	₹3 Cr	₹0	₹0	₹0	₹0
₹593 Cr	₹402 Cr	₹7 Cr	₹489 Cr	₹497 Cr	₹447 Cr	₹263 Cr
—	—	—	—	—	—	—
₹96 Cr	₹69 Cr	₹62 Cr	₹71 Cr	₹61 Cr	₹59 Cr	₹59 Cr
₹118 Cr	₹83 Cr	₹23 Cr	₹29 Cr	₹19 Cr	₹22 Cr	₹12 Cr
₹0	₹71 L	₹0	₹5 Cr	₹23 Cr	-₹8 Cr	₹20 Cr
₹13 Cr	₹6 Cr	₹21 Cr	₹27 Cr	₹20 Cr	₹23 Cr	₹13 Cr
₹227 Cr	₹158 Cr	₹106 Cr	₹132 Cr	₹123 Cr	₹96 Cr	₹103 Cr
₹2363 Cr	₹1917 Cr	₹1281 Cr	₹986 Cr	₹909 Cr	₹789 Cr	₹603 Cr
₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹1 Cr	₹1 Cr	₹43 L
₹509 Cr	₹326 Cr	₹0	₹469 Cr	₹495 Cr	₹426 Cr	₹272 Cr
—	—	—	—	—	—	—
₹1781 Cr	₹1290 Cr	₹1005 Cr	₹965 Cr	₹891 Cr	₹802 Cr	₹576 Cr
₹397 Cr	₹312 Cr	₹288 Cr	₹245 Cr	₹207 Cr	₹172 Cr	₹141 Cr
₹1384 Cr	₹978 Cr	₹718 Cr	₹720 Cr	₹684 Cr	₹630 Cr	₹435 Cr
₹129 Cr	₹185 Cr	₹74 Cr	₹29 Cr	₹27 Cr	₹26 Cr	₹11 Cr
₹10 L	₹12 L	₹14 L	₹15 L	₹15 L	₹15 L	₹13 L
₹10 L	₹12 L	₹14 L	₹15 L	₹15 L	₹15 L	₹13 L
₹155 Cr	₹55 Cr	₹58 Cr	₹7 Cr	₹11 Cr	₹16 Cr	₹24 Cr
₹10 Cr	₹7 Cr	₹22 Cr	₹21 Cr	₹7 Cr	₹4 Cr	₹0
₹1678 Cr	₹1225 Cr	₹872 Cr	₹776 Cr	₹728 Cr	₹676 Cr	₹469 Cr
—	—	—	—	—	—	—
₹486 Cr	₹507 Cr	₹17 Cr	₹1 Cr	₹3 Cr	₹7 Cr	₹2 Cr
₹38 Cr	₹26 Cr	₹21 Cr	₹19 Cr	₹15 Cr	₹13 Cr	₹14 Cr
₹76 Cr	₹43 Cr	₹57 Cr	₹46 Cr	₹28 Cr	₹22 Cr	₹45 Cr
₹58 Cr	₹95 Cr	₹301 Cr	₹134 Cr	₹103 Cr	₹19 Cr	₹7 Cr
₹18 Cr	₹13 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹4 Cr	₹6 Cr
₹9 Cr	₹7 Cr	₹7 Cr	₹4 Cr	₹28 Cr	₹47 Cr	₹59 Cr
₹685 Cr	₹693 Cr	₹410 Cr	₹209 Cr	₹180 Cr	₹113 Cr	₹134 Cr
₹458 Cr	₹534 Cr	₹304 Cr	₹77 Cr	₹57 Cr	₹17 Cr	₹31 Cr
₹2363 Cr	₹1917 Cr	₹1281 Cr	₹986 Cr	₹909 Cr	₹789 Cr	₹603 Cr
₹236	₹207	₹178	₹65	₹57	₹47	₹47
₹236	₹207	₹178	₹65	₹57	₹47	₹47

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
₹265 Cr	₹261 Cr	₹195 Cr	₹129 Cr	₹77 Cr	₹2 Cr	₹33 Cr
₹88 Cr	₹49 Cr	₹50 Cr	₹76 Cr	₹77 Cr	₹68 Cr	₹66 Cr
-₹21 Cr	₹21 Cr	-₹81 Cr	-₹54 Cr	-₹9 Cr	₹63 Cr	-₹9 Cr
₹332 Cr	₹331 Cr	₹164 Cr	₹150 Cr	₹146 Cr	₹133 Cr	₹89 Cr
₹268 Cr	₹267 Cr	₹115 Cr	₹117 Cr	₹137 Cr	₹123 Cr	₹74 Cr
-₹442 Cr	-₹497 Cr	-₹246 Cr	-₹104 Cr	-₹85 Cr	-₹296 Cr	-₹43 Cr
₹136 Cr	₹297 Cr	₹128 Cr	₹18 Cr	₹33 Cr	₹185 Cr	-₹32 Cr
-₹38 Cr	₹66 Cr	-₹3 Cr	₹31 Cr	₹85 Cr	₹12 Cr	-₹92 L
₹93 Cr	₹26 Cr	₹26 Cr	₹103 Cr	₹18 Cr	₹7 Cr	₹8 Cr
₹55 Cr	₹93 Cr	₹23 Cr	₹134 Cr	₹103 Cr	₹19 Cr	₹7 Cr

Fundamental Ratios

Consolidated

Standalone

Jupiter Life Line Hospitals Share Price

267.80+0.00 (-2.28%)

-11.84% past 1 Year

Shareholding summary

Promoters

40.91%

FII

9.37%

DII

2.2%

10.89%

Others

36.63%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
40.91%	40.91%	40.91%	40.91%	40.91%	40.91%
9.37%	8.48%	8.48%	9.06%	9.77%	10.04%
2.20%	2.62%	2.47%	2.56%	1.35%	1.13%
10.89%	10.97%	11.55%	10.99%	11.05%	11.09%
36.63%	37.02%	36.59%	36.48%	36.92%	36.83%

Bulk & block deals

Name

Hdfc Mutual Fund

Mitul Nitin Thakker

Arvind Rao Rao Kamini

Hdfc Mutual Fund

Mitul Nitin Thakker

Arvind Rao Rao Kamini

Sbi Mutual Fund

Think India Opportunities Master Fund Lp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
15 Jul 2026	Purchase	139 Cr	₹1,483.50	9.37 L	Bulk	0.285819	BSE
15 Jul 2026	Sell	89.01 Cr	₹1,483.50	6 L	Bulk	0.183022	BSE
15 Jul 2026	Sell	49.99 Cr	₹1,483.50	3.37 L	Bulk	0.102797	BSE
15 Jul 2026	Purchase	89.01 Cr	₹1,483.50	6 L	Block	0.183022	BSE
15 Jul 2026	Purchase	49.99 Cr	₹1,483.50	3.37 L	Block	0.102797	BSE
15 Jul 2026	Sell	89.01 Cr	₹1,483.50	6 L	Block	0.183022	BSE
15 Jul 2026	Sell	49.99 Cr	₹1,483.50	3.37 L	Block	0.102797	BSE
13 Nov 2025	Purchase	346.53 Cr	₹1,497.80	23.14 L	Bulk	0.705736	NSE
13 Nov 2025	Sell	346.53 Cr	₹1,497.80	23.14 L	Bulk	0.705735	NSE
29 Aug 2024	Purchase	26.20 Cr	₹1,310	2 L	Block	0.061007	NSE

Insider trading & SAST

Client name

Sbi Mutual Funds

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
26 Sep 2023	—	Acquisition	6.04	7.48	0	—	39.65 L	18 Sep 2023	Market	49,07,057	SAST	29(1)	—

Jupiter Life Line Hospitals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Jupiter Life Line Hospitals Share Price

Jupiter Life Line Hospitals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Jupiter Life Line Hospitals Share Price

Jupiter Life Line Hospitals Share Price

Oscillators

Moving averages

Jupiter Life Line Hospitals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Jupiter Life Line Hospitals Share Price

Corporate Actions

Company details

Jupiter Life Line Hospitals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Jupiter Life Line Hospitals Share Price

News

Jupiter Life Line Hospitals to host analyst and investor meet on September 28

Jupiter Life Line Hospitals unit acquires 100 percent stake in Sulcus Private

Jupiter Life Line Hospitals appoints new Chief Financial Officer Harshad Purani

Jupiter Life Line Hospitals Q1 EBITDA edges up but margin contracts sharply YoY

Jupiter Life Line Hospitals reports Q1 revenue rises to Rs 410 crores

Jupiter Life Line Hospitals reports weaker Q1 profit on year-on-year basis

Jupiter Life Line Hospitals schedules Q1 earnings call for August 3

Jupiter Life Line Hospitals Q4 EBITDA rises year-on-year, margin slightly softens

Jupiter Life Line Hospitals Q4 profit and revenue rise strongly on YoY basis

Jupiter Life Line reports Profit after tax of 49.20 Crores, in the March 2026 quarter

Jupiter Life Line Hospitals Secures MMRDA Approval for 80-Year Land Lease Valued at Rs 354 Crores.

Nuvama Maintains Buy on Jupiter Life Line Hospitals with Rs 1,475 Target Price.

Jupiter Life Line Hospitals informs about press release

Jupiter Life Line - Quaterly Results

Jupiter Life Line Hospitals Q3 EBITDA Rises 9.4% YoY to Rs 83.50 Crores with Stable Margin.

Jupiter Life Line Hospitals Q3FY26 Net Profit Declines 18% YoY to Rs 42.60 Crores, Revenue Up 10% to Rs 365 Crores.

Jupiter Life Line reports Profit after tax of 44.28 Crores, in the December 2025 quarter

Jupiter Life Line - Quaterly Results

Jupiter Life Line Hospitals targets 15% revenue growth via Western India expansions; Q2 FY26 income rises

Jupiter Life Line Hospitals Q2 FY26 posts growth in profit, revenue and EBITDA margins.

Jupiter Life Line Hospitals Ltd Share Price Today

Jupiter Life Line Hospitals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator